Status:

WITHDRAWN

A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise

Lead Sponsor:

GlaxoSmithKline

Conditions:

Asthma

Eligibility:

All Genders

12-50 years

Phase:

PHASE3

Brief Summary

The primary objective of this study is to demonstrate that the combination of inhaled fluticasone furoate/vilanterol (100 mcg/25 mcg) once daily provides superior protection throughout the day against...

Eligibility Criteria

Inclusion

  • Outpatient male or female 12 to 50 years of age
  • Females of child-bearing potential must be willing to use birth control or commit to abstinence during the study
  • Diagnosis of persistent asthma for at least 6 months
  • Best pre-bronchodilator FEV1 of at least 70%.
  • Current use of a low- to moderate-dose inhaled corticosteroid
  • Ability to withhold albuterol 6 hours prior to visits.
  • Physically able to perform exercise testing on a treadmill when albuterol has been withheld

Exclusion

  • Intermittent asthma, seasonal asthma, or exercise-induced asthma only
  • Symptomatic allergic rhinitis and/or thrush
  • Abnormal, clinically significant electrocardigraph
  • Respiratory infection within 4 weeks of first visit leading to asthma medication change or could affect subjects's asthma status or participation
  • Asthma exacerbation within 12 weeks of first visit
  • Respiratory diseases or other concurrent disease that would put subject at risk or confound results interpretation
  • Investigational medicines within 30 days of first visit or less than five half-lives of medication in prior study
  • Allergy to study drugs or study drug excipients
  • Concomitant medications that could interact with study medications or affect the course of asthma
  • Tobacco use within last year and/or a 10 pack-years history
  • Inability to comply with requirements of the study
  • Affiliation with investigator's site (example: family member)

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01435902

Start Date

January 1 2012

End Date

August 1 2012

Last Update

June 23 2014

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise | DecenTrialz